Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012
- PMID: 25824865
- PMCID: PMC4515376
- DOI: 10.1016/j.semarthrit.2015.02.010
Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012
Abstract
Background: Patients with giant cell arteritis (GCA) may experience serious vascular and visual complications. It is unknown, however, to what extent the difficulties of the disease may lead to hospitalization. The goal of this study is to discern whether patients with GCA are at greater risk for all-cause hospitalizations when compared to the general population.
Methods: This retrospective, population-based cohort study utilized patients with large vessel or visual involvement who were diagnosed with GCA (as defined by the 1990 ACR criteria) between 1/1/1950 and 12/31/2009, and a reference cohort of patients without GCA matched on age, sex, and calendar year. Each patients' medical record was examined for hospitalizations from 1987 through 2012. For this analysis, follow-up began with the latter of index date or 1/1/1987 and ended at the earlier of death, emigration from Olmsted County, or 12/31/2012. Discharge diagnoses were grouped together using the Clinical Classifications Software (CCS) for ICD-9-CM from Healthcare Cost and Utilization Project (HCUP). Data were analyzed using person-year methods and rate ratios comparing GCA to non-GCA.
Results: The GCA cohort consists of 199 patients with a mean age of 76.2 (79.9% female) and follow-up of 8.2 years. The non-GCA cohort is comprised of 194 patients with a mean age of 75.7 (78.9% female) and follow-up of 8.6 years. The patients with GCA had 816 hospitalizations and the non-GCA patients had 737 hospitalizations. GCA patients proved to be at a marginally greater risk for all causes of hospitalization [rate ratio (RR) = 1.13; 95% confidence interval (CI): 1.02-1.25]; however, the rate of hospitalization for patients with and without GCA decreased significantly from 1987 to 2012. Two specific discharge categories are of interest. First, transient cerebral ischemia is a greater risk of hospitalization for patients with GCA who had 16 hospitalizations compared to patients without GCA who only had 5 hospitalizations (RR = 3.06; 95% CI: 1.27-9.47). Second, patients with GCA (21 hospitalizations) are at greater risk of hospitalization for syncope than patients without GCA (5 hospitalizations) (RR = 3.98; 95% CI: 1.72-12.14).
Conclusion: In this first ever analysis of all-cause hospitalizations in a population-based cohort, patients with GCA appear to be at a marginally greater risk for hospitalization than patients without GCA, although the rate of hospitalization for GCA patients decreased from 1987 to 2012. Patients with GCA are at increased risk of hospitalization for both transient cerebral ischemia and syncope.
Keywords: Giant cell arteritis; Health utilization; Hospitalization.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors do not have any financial conflicts of interest for the work reported herein.
Figures
Similar articles
-
Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.Semin Arthritis Rheum. 2017 Apr;46(5):650-656. doi: 10.1016/j.semarthrit.2016.10.001. Epub 2016 Oct 13. Semin Arthritis Rheum. 2017. PMID: 27839741
-
Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden.Scand J Rheumatol. 2013;42(6):487-97. doi: 10.3109/03009742.2013.793777. Epub 2013 Jul 2. Scand J Rheumatol. 2013. PMID: 23815287
-
Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study.J Rheumatol. 2014 Dec;41(12):2447-51. doi: 10.3899/jrheum.140124. Epub 2014 Oct 15. J Rheumatol. 2014. PMID: 25320223 Free PMC article.
-
[Giant cell arteritis. A study of 191 patients].Med Clin (Barc). 1995 Dec 2;105(19):734-7. Med Clin (Barc). 1995. PMID: 8523954 Review. Spanish.
-
Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.Mod Rheumatol. 2016;26(3):410-4. doi: 10.3109/14397595.2015.1081722. Epub 2015 Sep 18. Mod Rheumatol. 2016. PMID: 26381748 Review.
Cited by
-
Analysis of Emergency Department Visits by Patients With Giant Cell Arteritis: A National Population-Based Study.Cureus. 2023 Feb 17;15(2):e35121. doi: 10.7759/cureus.35121. eCollection 2023 Feb. Cureus. 2023. PMID: 36945258 Free PMC article.
-
Burden, Causes, and Outcomes of Hospitalization in Patients With Giant Cell Arteritis: A US National Cohort Study.Arthritis Care Res (Hoboken). 2023 Aug;75(8):1830-1837. doi: 10.1002/acr.25081. Epub 2023 Feb 28. Arthritis Care Res (Hoboken). 2023. PMID: 36576029 Free PMC article.
-
Non-steroidal Anti-inflammatory Drug Use and Risk of Age-Related Macular Degeneration in the California Teachers Study.Drugs Aging. 2021 Sep;38(9):817-828. doi: 10.1007/s40266-021-00885-z. Epub 2021 Jul 26. Drugs Aging. 2021. PMID: 34309807 Free PMC article.
-
Hospitalization Rates Are Highest in the First 5 Years of Systemic Sclerosis: Results From a Population-based Cohort (1980-2016).J Rheumatol. 2021 Jun;48(6):877-882. doi: 10.3899/jrheum.200737. Epub 2020 Nov 15. J Rheumatol. 2021. PMID: 33191288 Free PMC article.
-
Does low risk of infections as a marker of effective immunity predict increased risk of subsequent giant cell arteritis or polymyalgia rheumatica? A Danish population-based case-control study.Clin Epidemiol. 2018 Oct 16;10:1533-1543. doi: 10.2147/CLEP.S158293. eCollection 2018. Clin Epidemiol. 2018. PMID: 30425584 Free PMC article.
References
-
- Boesen P, Sørensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county: a prospective investigation, 1982–1985. Arthritis Rheum. 1987;30(1):294–299. - PubMed
-
- Machado EB, Michet CJ, Ballard DJ, Hunder GG, Beard CM, Chu CP, et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950–1985. Arthritis Rheum. 1988;31(6):745–749. - PubMed
-
- Baldursson O, Steinsson K, Björnsson J, Lie JT. Giant cell arteritis in Iceland: an epidemiologic and histopathologic analysis. Arthritis Rheum. 1994;37(1):1007–12. - PubMed
-
- Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987–94. J Rheumatol. 1997;24(1):1739–1743. - PubMed
-
- Haugeberg G, Paulsen PQ, Bie RB. Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings. J Rheumatol. 2000;27(1):2624–2627. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
